Kevin H. Mayo - Publications

Affiliations: 
University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Biochemistry
Website:
https://cbs.umn.edu/contacts/kevin-h-mayo

128 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zheng Y, Su J, Miller MC, Geng J, Xu X, Zhang T, Mayzel M, Zhou Y, Mayo KH, Tai G. Topsy-turvy binding of negatively charged homogalacturonan oligosaccharides to galectin-3. Glycobiology. PMID 32909036 DOI: 10.1093/Glycob/Cwaa080  0.321
2020 Miller MC, Nesmelova IV, Daragan VA, Ippel H, Michalak M, Dregni A, Kaltner H, Kopitz J, Gabius HJ, Mayo KH. Pro4 prolyl peptide bond isomerization in human galectin-7 modulates the monomer-dimer equilibrum to affect function. The Biochemical Journal. PMID 32766716 DOI: 10.1042/Bcj20200499  0.403
2020 Si Y, Li Y, Yang T, Li X, Ayala GJ, Mayo KH, Tai G, Su J, Zhou Y. Structure-function studies of galectin-14, an important effector molecule in embryology. The Febs Journal. PMID 32525264 DOI: 10.1111/Febs.15441  0.325
2020 Eckardt V, Miller MC, Blanchet X, Duan R, Leberzammer J, Duchene J, Soehnlein O, Megens RT, Ludwig AK, Dregni A, Faussner A, Wichapong K, Ippel H, Dijkgraaf I, Kaltner H, ... ... Mayo KH, et al. Chemokines and galectins form heterodimers to modulate inflammation. Embo Reports. e47852. PMID 32080959 DOI: 10.15252/Embr.201947852  0.314
2018 Miller MC, Zheng Y, Zhou Y, Tai G, Mayo KH. Galectin-3 binds selectively to the terminal, non-reducing end of β(1→4)-galactans, with overall affinity increasing with chain length. Glycobiology. PMID 30204870 DOI: 10.1093/Glycob/Cwy085  0.325
2018 Zheng Y, Li L, Feng Z, Wang H, Mayo KH, Zhou Y, Tai G. Preparation of individual galactan oligomers, their prebiotic effects, and use in estimating galactan chain length in pectin-derived polysaccharides. Carbohydrate Polymers. 199: 526-533. PMID 30143159 DOI: 10.1016/J.Carbpol.2018.07.048  0.312
2018 Miller MC, Ludwig AK, Wichapong K, Kaltner H, Kopitz J, Gabius HJ, Mayo KH. Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimers. The Biochemical Journal. PMID 29321242 DOI: 10.1042/Bcj20170658  0.344
2017 Zhang T, Miller MC, Zheng Y, Zhang Z, Xue H, Zhao D, Su J, Mayo KH, Zhou Y, Tai G. Macromolecular Assemblies of Complex Polysaccharides with Galectin-3 and Their Synergestic Effects on Function. The Biochemical Journal. PMID 28986508 DOI: 10.1042/Bcj20170143  0.316
2017 Miller MC, Zheng Y, Yan J, Zhou Y, Tai G, Mayo KH. Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization. Glycobiology. PMID 28973299 DOI: 10.1093/Glycob/Cwx071  0.34
2017 von Hundelshausen P, Agten SM, Eckardt V, Blanchet X, Schmitt MM, Ippel H, Neideck C, Bidzhekov K, Leberzammer J, Wichapong K, Faussner A, Drechsler M, Grommes J, van Geffen JP, Li H, ... ... Mayo KH, et al. Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation. Science Translational Medicine. 9. PMID 28381538 DOI: 10.1126/Scitranslmed.Aah6650  0.373
2016 Ippel H, Miller MC, Vértesy S, Zhang Y, Cañada FJ, Suylen D, Umemoto K, Romanò C, Hackeng T, Tai G, Leffler H, Kopitz J, André S, Kübler D, Jiménez-Barbero J, ... ... Mayo KH, et al. Intra- and inter-molecular interactions of human galectin-3: assessment by full-assignment-based NMR. Glycobiology. PMID 26911284 DOI: 10.1093/Glycob/Cww021  0.4
2016 Miller MC, Ippel H, Suylen D, Klyosov AA, Traber PG, Hackeng T, Mayo KH. Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain. Glycobiology. 26: 88-99. PMID 26646771 DOI: 10.1093/Glycob/Cwv073  0.305
2015 Vértesy S, Michalak M, Miller MC, Schnölzer M, André S, Kopitz J, Mayo KH, Gabius HJ. Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presence. Protein Engineering, Design & Selection : Peds. 28: 199-210. PMID 25796447 DOI: 10.1093/Protein/Gzv014  0.341
2015 Läppchen T, Dings RP, Rossin R, Simon JF, Visser TJ, Bakker M, Walhe P, van Mourik T, Donato K, van Beijnum JR, Griffioen AW, Lub J, Robillard MS, Mayo KH, Grüll H. Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[(18)F]fluoroethylazide, and in vivo evaluation. European Journal of Medicinal Chemistry. 89: 279-95. PMID 25462244 DOI: 10.1016/J.Ejmech.2014.10.048  0.301
2015 Rauthu SR, Shiao TC, André S, Miller MC, Madej É, Mayo KH, Gabius HJ, Roy R. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis. Chembiochem : a European Journal of Chemical Biology. 16: 126-39. PMID 25407851 DOI: 10.1002/Cbic.201402474  0.332
2015 Ippel H, Miller MC, Berbís MA, Suylen D, André S, Hackeng TM, Cañada FJ, Weber C, Gabius HJ, Jiménez-Barbero J, Mayo KH. (1)H, (13)C, and (15)N backbone and side-chain chemical shift assignments for the 36 proline-containing, full length 29 kDa human chimera-type galectin-3. Biomolecular Nmr Assignments. 9: 59-63. PMID 24504927 DOI: 10.1007/S12104-014-9545-3  0.386
2014 Berbís MÁ, André S, Cañada FJ, Pipkorn R, Ippel H, Mayo KH, Kübler D, Gabius HJ, Jiménez-Barbero J. Peptides derived from human galectin-3 N-terminal tail interact with its carbohydrate recognition domain in a phosphorylation-dependent manner. Biochemical and Biophysical Research Communications. 443: 126-31. PMID 24269589 DOI: 10.1016/J.Bbrc.2013.11.063  0.362
2013 Ermakova E, Miller MC, Nesmelova IV, López-Merino L, Berbís MA, Nesmelov Y, Tkachev YV, Lagartera L, Daragan VA, André S, Cañada FJ, Jiménez-Barbero J, Solís D, Gabius HJ, Mayo KH. Lactose binding to human galectin-7 (p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity. Glycobiology. 23: 508-23. PMID 23376190 DOI: 10.1093/Glycob/Cwt005  0.337
2013 Dings RP, Kumar N, Miller MC, Loren M, Rangwala H, Hoye TR, Mayo KH. Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1. The Journal of Pharmacology and Experimental Therapeutics. 344: 589-99. PMID 23232447 DOI: 10.1124/Jpet.112.199646  0.381
2012 Dings RP, Miller MC, Nesmelova I, Astorgues-Xerri L, Kumar N, Serova M, Chen X, Raymond E, Hoye TR, Mayo KH. Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding. Journal of Medicinal Chemistry. 55: 5121-9. PMID 22575017 DOI: 10.1021/Jm300014Q  0.336
2012 Nesmelova IV, Berbís MÁ, Miller MC, Cañada FJ, André S, Jiménez-Barbero J, Gabius HJ, Mayo KH. 1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 31 kDa human galectin-7 (p53-induced gene 1) homodimer, a pro-apoptotic lectin. Biomolecular Nmr Assignments. 6: 127-9. PMID 21898049 DOI: 10.1007/S12104-011-9339-9  0.318
2012 Dings RPM, Miller MC, Kumar N, Mayo KH. Abstract LB-3: Evidence that dibenzofuran based anti-angiogenic, anti-tumor peptidomimetics target galectin-1 Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-3  0.372
2011 McNiel EA, Madrill NJ, Esteves-Villanueva JO, Dominguez PA, Dings R, Mayo KH, Griffin RJ. Abstract 3293: Activity and safety of an antiangiogenic peptide in spontaneous head and neck squamous cell carcinoma in cats Cancer Research. 71: 3293-3293. DOI: 10.1158/1538-7445.Am2011-3293  0.326
2011 Dings RPM, Miller MM, Mayo KH. Abstract B9: Evidence that the small molecule antiangiogenic agent PTX008 targets galectin-1. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B9  0.356
2010 Nesmelova IV, Ermakova E, Daragan VA, Pang M, Menéndez M, Lagartera L, Solís D, Baum LG, Mayo KH. Lactose binding to galectin-1 modulates structural dynamics, increases conformational entropy, and occurs with apparent negative cooperativity. Journal of Molecular Biology. 397: 1209-30. PMID 20184898 DOI: 10.1016/J.Jmb.2010.02.033  0.352
2010 Klein MA, Mayo KH, Kratzke RA. p16(INK4a) Peptide mimetics identified via virtual screening. Bioorganic & Medicinal Chemistry Letters. 20: 403-5. PMID 19914831 DOI: 10.1016/J.Bmcl.2009.10.046  0.325
2010 Nesmelova IV, Ermakova E, Daragan VA, Pang M, Baum LG, Mayo KH. Lactose Binding To Galectin-1 Occurs With Negative Cooperativity and Attenuates Internal Motions Throughout the Protein Biophysical Journal. 98: 36a. DOI: 10.1016/J.Bpj.2009.12.209  0.358
2009 Miller MC, Klyosov A, Mayo KH. The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain. Glycobiology. 19: 1034-45. PMID 19541770 DOI: 10.1093/Glycob/Cwp084  0.341
2009 Miller MC, Nesmelova IV, Platt D, Klyosov A, Mayo KH. The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface. The Biochemical Journal. 421: 211-21. PMID 19432560 DOI: 10.1042/Bj20090265  0.35
2009 Dings RPM, Miller MC, Loren ML, Mayo KH. Abstract C105: Preclinical evaluation of galectin‐1 targeting antiangiogenic, antitumor peptidomimetics Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-C105  0.34
2009 Levine JI, Dings RPM, Loren ML, Hoye TR, Mayo KH. Abstract A141: Synthesis and bioactivity of core‐expanded calixarene‐based antitumor agents Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A141  0.398
2008 Nesmelova IV, Pang M, Baum LG, Mayo KH. 1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 29 kDa human galectin-1 protein dimer. Biomolecular Nmr Assignments. 2: 203-5. PMID 19636905 DOI: 10.1007/S12104-008-9121-9  0.331
2008 Dings RP, Haseman JR, Mayo KH. Probing structure-activity relationships in bactericidal peptide betapep-25. The Biochemical Journal. 414: 143-50. PMID 18489259 DOI: 10.1042/Bj20080506  0.421
2007 Dings RP, Mayo KH. A journey in structure-based drug discovery: from designed peptides to protein surface topomimetics as antibiotic and antiangiogenic agents. Accounts of Chemical Research. 40: 1057-65. PMID 17661438 DOI: 10.1021/Ar700086K  0.451
2007 Arroyo MM, Mayo KH. NMR solution structure of the angiostatic peptide anginex. Biochimica Et Biophysica Acta. 1774: 645-51. PMID 17478129 DOI: 10.1016/J.Bbapap.2007.03.007  0.793
2007 Amano M, Suzuki M, Andoh S, Monzen H, Terai K, Williams B, Song CW, Mayo KH, Hasegawa T, Dings RP, Griffin RJ. Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay. International Journal of Clinical Oncology. 12: 42-7. PMID 17380440 DOI: 10.1007/S10147-006-0625-Y  0.307
2007 Brandwijk RJ, Mulder WJ, Nicolay K, Mayo KH, Thijssen VL, Griffioen AW. Anginex-conjugated liposomes for targeting of angiogenic endothelial cells. Bioconjugate Chemistry. 18: 785-90. PMID 17378601 DOI: 10.1021/Bc060316H  0.314
2007 Orsini MJ, Klein MA, Beavers MP, Connolly PJ, Middleton SA, Mayo KH. Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. Journal of Medicinal Chemistry. 50: 462-71. PMID 17266198 DOI: 10.1021/Jm0609824  0.434
2006 Chen X, Dings RP, Nesmelova I, Debbert S, Haseman JR, Maxwell J, Hoye TR, Mayo KH. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins. Journal of Medicinal Chemistry. 49: 7754-65. PMID 17181157 DOI: 10.1021/Jm0610447  0.414
2006 Dings RP, Chen X, Hellebrekers DM, van Eijk LI, Zhang Y, Hoye TR, Griffioen AW, Mayo KH. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities. Journal of the National Cancer Institute. 98: 932-6. PMID 16818857 DOI: 10.1093/Jnci/Djj247  0.38
2006 Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, Kwee L, Mayo KH, Wagstaff J, Bouma-ter Steege JC, Griffioen AW. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 621-30. PMID 16581970 DOI: 10.1096/Fj.05-4493Com  0.312
2005 Brandwijk RJ, Nesmelova I, Dings RP, Mayo KH, Thijssen VL, Griffioen AW. Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein. Biochemical and Biophysical Research Communications. 333: 1261-8. PMID 15979575 DOI: 10.1016/J.Bbrc.2005.06.029  0.423
2005 Orsini MJ, Nesmelova I, Young HC, Hargittai B, Beavers MP, Liu J, Connolly PJ, Middleton SA, Mayo KH. The nociceptin pharmacophore site for opioid receptor binding derived from the NMR structure and bioactivity relationships. The Journal of Biological Chemistry. 280: 8134-42. PMID 15596448 DOI: 10.1074/Jbc.M406405200  0.376
2005 Nesmelova IV, Sham Y, Dudek AZ, van Eijk LI, Wu G, Slungaard A, Mortari F, Griffioen AW, Mayo KH. Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level. The Journal of Biological Chemistry. 280: 4948-58. PMID 15531763 DOI: 10.1074/Jbc.M405364200  0.321
2004 Wasiluk KR, Leslie DB, Vietzen PS, Mayo KH, Dunn DL. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein. Surgery. 136: 253-60. PMID 15300188 DOI: 10.1016/J.Surg.2004.04.028  0.431
2004 Chu-Kung AF, Bozzelli KN, Lockwood NA, Haseman JR, Mayo KH, Tirrell MV. Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconjugate Chemistry. 15: 530-5. PMID 15149180 DOI: 10.1021/Bc0341573  0.788
2004 Lockwood NA, Haseman JR, Tirrell MV, Mayo KH. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. The Biochemical Journal. 378: 93-103. PMID 14609430 DOI: 10.1042/Bj20031393  0.789
2003 Dings RP, Nesmelova I, Griffioen AW, Mayo KH. Discovery and development of anti-angiogenic peptides: A structural link. Angiogenesis. 6: 83-91. PMID 14739615 DOI: 10.1023/B:Agen.0000011730.94233.06  0.392
2003 Mayo KH, Dings RP, Flader C, Nesmelova I, Hargittai B, van der Schaft DW, van Eijk LI, Walek D, Haseman J, Hoye TR, Griffioen AW. Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity. The Journal of Biological Chemistry. 278: 45746-52. PMID 12947097 DOI: 10.1074/Jbc.M308608200  0.426
2003 Idiyatullin D, Nesmelova I, Daragan VA, Mayo KH. Comparison of (13)C(alpha)H and (15)NH backbone dynamics in protein GB1. Protein Science : a Publication of the Protein Society. 12: 914-22. PMID 12717014 DOI: 10.1110/Ps.0228703  0.305
2003 Dings RP, Arroyo MM, Lockwood NA, van Eijk LI, Haseman JR, Griffioen AW, Mayo KH. Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide. The Biochemical Journal. 373: 281-8. PMID 12708970 DOI: 10.1042/Bj20030295  0.767
2003 Dings RP, van der Schaft DW, Hargittai B, Haseman J, Griffioen AW, Mayo KH. Anti-tumor activity of the novel angiogenesis inhibitor anginex. Cancer Letters. 194: 55-66. PMID 12706859 DOI: 10.1016/S0304-3835(03)00015-6  0.308
2003 Idiyatullin D, Nesmelova I, Daragan VA, Mayo KH. Heat capacities and a snapshot of the energy landscape in protein GB1 from the pre-denaturation temperature dependence of backbone NH nanosecond fluctuations. Journal of Molecular Biology. 325: 149-62. PMID 12473458 DOI: 10.1016/S0022-2836(02)01155-5  0.316
2003 Lockwood NA, Mayo KH. The future for antibiotics: Bacterial membrane disintegrators Drugs of the Future. 28: 911-923. DOI: 10.1358/Dof.2003.028.09.857379  0.751
2003 Mayo KH, Griffioen AW. Designing βpep peptides: A rational approach to the discovery of novel pharmaceutical agents and small molecules Drugs of the Future. 28: 337-346. DOI: 10.1358/Dof.2003.028.04.740190  0.427
2002 Lockwood NA, van Tankeren R, Mayo KH. Aqueous gel formation of a synthetic peptide derived from the beta-sheet domain of platelet factor-4. Biomacromolecules. 3: 1225-32. PMID 12425659 DOI: 10.1021/Bm025573D  0.765
2002 van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW. The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1991-3. PMID 12397082 DOI: 10.1096/Fj.02-0509Fje  0.327
2002 van der Schaft DW, Wagstaff J, Mayo KH, Griffioen AW. The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI). Annals of Medicine. 34: 19-27. PMID 12014429 DOI: 10.1080/078538902317338607  0.303
2001 Bouma-ter Steege JCA, Mayo KH, Griffioen AW. Angiostatic proteins and peptides Critical Reviews in Eukaryotic Gene Expression. 11: 319-333. PMID 12067070 DOI: 10.1615/Critreveukargeneexpr.V11.I4.40  0.329
2001 Mayo KH, Van Der Schaft DWJ, Griffioen AW. Designed β-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells Angiogenesis. 4: 45-51. PMID 11824378 DOI: 10.1023/A:1016672117477  0.435
2001 Chang SL, Wallar BJ, Lipscomb JD, Mayo KH. Residues in Methylosinus trichosporium OB3b methane monooxygenase component B involved in molecular interactions with reduced- and oxidized-hydroxylase component: a role for the N-terminus. Biochemistry. 40: 9539-51. PMID 11583153 DOI: 10.1021/Bi0103462  0.581
2001 Idiyatullin D, Daragan VA, Mayo KH. A new approach to visualizing spectral density functions and deriving motional correlation time distributions: Applications to an α-helix-forming peptide and to a well-folded protein Journal of Magnetic Resonance. 152: 132-148. PMID 11531372 DOI: 10.1006/Jmre.2001.2372  0.313
2001 Cox A, Arroyo MM, Mayo KH. Folding of beta pep-4 beta-sheet sandwich dimers and tetramers is influenced by aliphatic hydrophobic residues at the intersubunit interface. The Biochemical Journal. 357: 739-47. PMID 11463344 DOI: 10.1042/0264-6021:3570739  0.763
2001 Nesmelova I, Krushelnitsky A, Idiyatullin D, Blanco F, Ramirez-Alvarado M, Daragan VA, Serrano L, Mayo KH. Conformational exchange on the microsecond time scale in alpha-helix and beta-hairpin peptides measured by 13C NMR transverse relaxation. Biochemistry. 40: 2844-53. PMID 11258895 DOI: 10.1021/Bi001293B  0.445
2001 Griffioen AW, Van der Schaft DWJ, Barendsz-Janson AF, Cox A, Struijker Boudier HAJ, Hillen HFP, Mayo KH. Anginex, a designed peptide that inhibits angiogenesis Biochemical Journal. 354: 233-242. PMID 11171099 DOI: 10.1042/0264-6021:3540233  0.426
2000 Beavers MP, Gunnet JW, Hageman W, Miller W, Moore JB, Zhou L, Chen RHK, Xiang A, Urbanski M, Combs DW, Mayo KH, Demarest KT. Discovery of the first non-peptide antagonist of the motilin receptor Drug Design and Discovery. 17: 243-251. PMID 11469754  0.333
2000 Idiyatullin D, Krushelnitsky A, Nesmelova I, Blanco F, Daragan VA, Serrano L, Mayo KH. Internal motional amplitudes and correlated bond rotations in an α-helical peptide derived from 13C and 15N NMR relaxation Protein Science. 9: 2118-2127. PMID 11152123 DOI: 10.1110/Ps.9.11.2118  0.338
2000 Mayo KH, Daragan VA, Idiyatullin D, Nesmelova I. Peptide Internal Motions on Nanosecond Time Scale Derived from Direct Fitting of 13C and 15N NMR Spectral Density Functions Journal of Magnetic Resonance. 146: 188-195. PMID 10968972 DOI: 10.1006/Jmre.2000.2148  0.328
2000 Mayo KH, Haseman J, Young HC, Mayo JW. Structure-function relationships in novel peptide dodecamers with broad-spectrum bactericidal and endotoxin-neutralizing activities Biochemical Journal. 349: 717-728. PMID 10903132 DOI: 10.1042/Bj3490717  0.432
2000 Mayo KH. Recent advances in the design and construction of synthetic peptides: For the love of basics or just for the technology of it Trends in Biotechnology. 18: 212-217. PMID 10758516 DOI: 10.1016/S0167-7799(00)01439-6  0.416
1999 Mikhailov DV, Washington L, Voloshin AM, Daragan VA, Mayo KH. Angular variances for internal bond rotations of side chains in GXG-based tripeptides derived from (13)C-NMR relaxation measurements: Implications to protein folding. Biopolymers. 49: 373-383. PMID 11180046 DOI: 10.1002/(Sici)1097-0282(19990415)49:5<373::Aid-Bip4>3.0.Co;2-V  0.399
1999 Mikhailov D, Young HC, Linhardt RJ, Mayo KH. Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-α. Induction of a partially folded state and implications for heparin-induced thrombocytopenia Journal of Biological Chemistry. 274: 25317-25329. PMID 10464257 DOI: 10.1074/Jbc.274.36.25317  0.332
1999 Chang SL, Wallar BJ, Lipscomb JD, Mayo KH. Solution structure of component B from methane monooxygenase derived through heteronuclear NMR and molecular modeling. Biochemistry. 38: 5799-812. PMID 10231531 DOI: 10.1021/Bi982992F  0.546
1999 Young H, Roongta V, Daly TJ, Mayo KH. NMR structure and dynamics of monomeric neutrophil-activating peptide 2 Biochemical Journal. 338: 591-598. PMID 10051427 DOI: 10.1042/0264-6021:3380591  0.399
1999 Yu YC, Roontga V, Daragan VA, Mayo KH, Tirrell M, Fields GB. Structure and dynamics of peptide-amphiphiles incorporating triple-helical proteinlike molecular architecture. Biochemistry. 38: 1659-68. PMID 9931034 DOI: 10.1021/Bi982315L  0.6
1998 Mayo KH, Haseman J, Ilyina E, Gray B. Designed β-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities Biochimica Et Biophysica Acta - General Subjects. 1425: 81-92. PMID 9813253 DOI: 10.1016/S0304-4165(98)00053-1  0.403
1998 Ramirez-Alvarado M, Daragan VA, Serrano L, Mayo KH. Motional dynamics of residues in a beta-hairpin peptide measured by 13C-NMR relaxation. Protein Science : a Publication of the Protein Society. 7: 720-9. PMID 9541404 DOI: 10.1002/Pro.5560070321  0.377
1998 Mayo KH, Ilyina E. A folding pathway for βpep-4 peptide 33mer: From unfolded monomers and β-sheet sandwich dimers to well-structured tetramers Protein Science. 7: 358-368. PMID 9521112 DOI: 10.1002/Pro.5560070216  0.381
1998 Daragan VA, Mayo KH. A Simple Approach to Analyzing Protein Side-Chain Dynamics from 13C NMR Relaxation Data Journal of Magnetic Resonance. 130: 329-334. PMID 9500896 DOI: 10.1006/Jmre.1997.1310  0.342
1997 Mikhailov D, Linhardt RJ, Mayo KH. NMR solution conformation of heparin-derived hexasaccharide Biochemical Journal. 328: 51-61. PMID 9359833 DOI: 10.1042/Bj3280051  0.338
1997 Mayo KH. Solution nuclear magnetic resonance characterization of peptide folding Methods in Enzymology. 289: 646-672. PMID 9353743 DOI: 10.1016/S0076-6879(97)89069-6  0.459
1997 Uknis ME, Wasiluk KR, Acton RD, Klaerner HG, Dahlberg PS, Ilyina EE, Haseman JR, Gray BH, Mayo KH, Dunn DL. Design of a potent novel endotoxin antagonist Surgery. 122: 380-385. PMID 9288144 DOI: 10.1016/S0039-6060(97)90030-1  0.393
1997 Ilyina E, Roongta V, Mayo KH. NMR structure of a de novo designed, peptide 33mer with two distinct, compact β-sheet folds Biochemistry. 36: 5245-5250. PMID 9136886 DOI: 10.1021/Bi963064O  0.364
1997 Daragan VA, Ilyina EE, Fields CG, Fields GB, Mayo KH. Backbone and side-chain dynamics of residues in a partially folded β- sheet peptide from platelet factor-4 Protein Science. 6: 355-363. PMID 9041637 DOI: 10.1002/Pro.5560060211  0.365
1997 Mayo KH, Fields GB. Peptides as Models for Understanding Protein Folding Advances in Molecular and Cell Biology. 22: 567-612. DOI: 10.1016/S1569-2558(08)60486-5  0.394
1997 Ilyina E, Roongta V, Mayo KH. Designing water soluble β-sheet peptides with compact structure Techniques in Protein Chemistry. 8: 797-808. DOI: 10.1016/S1080-8914(97)80077-4  0.39
1997 Daragan VA, Mayo KH. Motional model analyses of protein and peptide dynamics using 13C and 15N NMR relaxation Progress in Nuclear Magnetic Resonance Spectroscopy. 31: 63-105. DOI: 10.1016/S0079-6565(97)00006-X  0.373
1996 Mayo KH, Ilyina E, Park H. A recipe for designing water-soluble, β-sheet-forming peptides Protein Science. 5: 1301-1315. PMID 8819163 DOI: 10.1002/Pro.5560050709  0.419
1996 Mayo KH. NMR and x-ray studies of collagen model peptides Biopolymers - Peptide Science Section. 40: 359-370. PMID 8765607 DOI: 10.1002/(Sici)1097-0282(1996)40:4<359::Aid-Bip2>3.0.Co;2-V  0.413
1996 Mayo KH, Fan F, Beavers MP, Eckardt A, Keane P, Hoekstra WJ, Andrade-Gordon P. NOE-derived conformation of GRGDSP cell adhesion recognition site in the presence of SDS micelles and integrin receptor GPIIB/IIIA Biochimica Et Biophysica Acta - Protein Structure and Molecular Enzymology. 1296: 95-102. PMID 8765234 DOI: 10.1016/0167-4838(96)00057-X  0.356
1996 Yao LJ, Mayo KH. Interactions of integrin GPIIb/IIIa-derived peptides with fibrinogen investigated by NMR spectroscopy Biochemical Journal. 315: 161-170. PMID 8670102 DOI: 10.1042/Bj3150161  0.45
1996 Mikhailov D, Mayo KH, Pervin A, Linhardt RJ. 13C-NMR relation study of heparin-disaccharide interactions with tripeptides GRG and GKG. The Biochemical Journal. 315: 447-54. PMID 8615813 DOI: 10.1042/Bj3150447  0.386
1996 Mayo KH, Fan F, Beavers MP, Eckardt A, Keane P, Hoekstra WJ, Andrade-Gordon P. Integrin receptor GPIIb/IIIa bound state conformation of the fibrinogen γ-chain C-terminal peptide 400-411: NMR and transfer NOE studies Biochemistry. 35: 4434-4444. PMID 8605193 DOI: 10.1021/Bi952485N  0.353
1996 Mayo KH, Fan F, Beavers MP, Eckardt A, Keane P, Hoekstra WJ, Andrade-Gordon P. RGD induces conformational transition in purified platelet integrin GPIIb/IIIa-SDS system yielding multiple binding states for fibrinogen γ-chain C-terminal peptide Febs Letters. 378: 79-82. PMID 8549808 DOI: 10.1016/0014-5793(95)01418-7  0.387
1996 Varnum JM, Thakur M, Mayo KH, Jansen SA. Stability and conformational analysis of Tc-RC160 and Re-RC160: Experimental and theoretical analysis of the influence of metal complexation on the structural requisites for activity Journal of Physical Chemistry. 100: 14630-14636. DOI: 10.1021/Jp960024L  0.392
1996 Daragan VA, Mayo KH. Analysis of Internally Restricted Correlated Rotations in Peptides and Proteins Using13C and15N NMR Relaxation Data The Journal of Physical Chemistry. 100: 8378-8388. DOI: 10.1021/Jp9531927  0.358
1996 Daragan VA, Mayo KH. A novel model-free analysis of 13C NMR relaxation of alanine-methyl side-chain motions in peptides Journal of Magnetic Resonance - Series B. 110: 164-175. DOI: 10.1006/Jmrb.1996.0026  0.343
1996 Mikhailov D, Mayo KH, Pervin A, Linhardt RJ. 13C-NMR relaxation study of heparin-disaccharide interactions with tripeptides GRG and GKG Biochemical Journal. 315: 447-454.  0.326
1995 Mayo KH, Ilyina E, Roongta V, Dundas M, Joseph J, Lai CK, Maione T, Daly TJ. Heparin binding to platelet factor-4 Biochemical Journal. 312: 357-365. PMID 8526843 DOI: 10.1042/Bj3120357  0.34
1995 Ilyina E, Mayo KH. Multiple native-like conformations trapped via self-association-induced hydrophobic collapse of the 33-residue β-sheet domain from platelet factor 4 Biochemical Journal. 306: 407-419. PMID 7887894 DOI: 10.1042/Bj3060407  0.412
1995 Barker S, Mayo KH. Quarternary structure amplification of protein folding differences observed in 'native' platelet factor-4 Febs Letters. 357: 301-304. PMID 7835432 DOI: 10.1016/0014-5793(94)01384-D  0.32
1995 Mikhailov D, Daragan VA, Mayo KH. 13C multiplet nuclear magnetic resonance relaxation-derived ring puckering and backbone dynamics in proline-containing glycine-based peptides Biophysical Journal. 68: 1540-1550. PMID 7787039 DOI: 10.1016/S0006-3495(95)80326-7  0.371
1995 Gray BH, Haseman JR, Mayo KH. B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides Bba - General Subjects. 1244: 185-190. PMID 7766657 DOI: 10.1016/0304-4165(95)00004-U  0.425
1995 Hoekstra WJ, Beavers MP, Andrade-Gordon P, Evangelisto MF, Keane PM, Press JB, Tomko KA, Fan F, Kloczewiak M, Mayo KH, Durkin KA, Liotta DC. Design and evaluation of nonpeptide fibrinogen γ-chain based GPIIb/IIIa antagonists Journal of Medicinal Chemistry. 38: 1582-1592. PMID 7752183 DOI: 10.1021/Jm00010A002  0.308
1995 Mikhailov D, Daragan VA, Mayo KH. Lysine side-chain dynamics derived from 13C-multiplet NMR relaxation studies on di- and tripeptides Journal of Biomolecular Nmr. 5: 397-410. PMID 7647558 DOI: 10.1007/Bf00182283  0.315
1995 Battafaraono RJ, Dahlberg PS, Ratz CA, Johnston JW, Gray BH, Haseman JR, Mayo KH, Dunn DL. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Surgery. 118: 318-24. PMID 7638748 DOI: 10.1016/S0039-6060(05)80340-X  0.314
1995 Fan F, Mayo KH. Effect of pH on the conformation and backbone dynamics of a 27-residue peptide in trifluoroethanol: An NMR and CD study Journal of Biological Chemistry. 270: 24693-24701. PMID 7559584 DOI: 10.1074/Jbc.270.42.24693  0.411
1995 Mayo KH, Roongta V, Ilyina E, Milius R, Barker S, Quinlan C, LaRosa G, Daly TJ. NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: A symmetric tetramer Biochemistry. 34: 11399-11409. PMID 7547867 DOI: 10.1021/Bi00036A012  0.374
1995 Daragan VA, Mayo KH. Using the Model-Free Approach to Interpret 13C NMR Multiplet Relaxation Data from Peptides and Proteins Journal of Magnetic Resonance, Series B. 107: 274-278. DOI: 10.1006/Jmrb.1995.1089  0.393
1994 Yang Y, Mayo KH, Daly TJ, Barry JK, La Rosa GJ. Subunit association and structural analysis of platelet basic protein and related proteins investigated by 1H NMR spectroscopy and circular dichroism Journal of Biological Chemistry. 269: 20110-20118. PMID 8051099  0.314
1994 Mayo KH, Yang Y, Daly TJ, Barry JK, La Rosa GJ. Secondary structure of neutrophil-activating peptide-2 determined by 1H-nuclear magnetic resonance spectroscopy Biochemical Journal. 304: 371-376. PMID 7998970 DOI: 10.1042/Bj3040371  0.394
1994 Ilyina E, Milius R, Mayo KH. Synthetic peptides probe folding initiation sites in platelet factor-4: stable chain reversal found within the hydrophobic sequence LIATLKNGRKISL. Biochemistry. 33: 13436-44. PMID 7947752 DOI: 10.1021/Bi00249A032  0.402
1994 Daragan VA, Mayo KH. Peptide dynamics in triglycine: Coupling of internal bond rotations and overall molecular tumbling Journal of Physical Chemistry. 98: 10949-10956. DOI: 10.1021/J100093A043  0.32
1993 Daragan VA, Ilyina E, Mayo KH. Effects of molecular association on structure and dynamics of a collagenous peptide Biopolymers. 33: 521-533. PMID 8467063 DOI: 10.1002/Bip.360330403  0.428
1993 Daragan VA, Kloczewiak MA, Mayo KH. 13C nuclear magnetic resonance relaxation-derived ψ, Ψ bond rotational energy barriers and rotational restrictions for glycine13Cα-methylenes in a GXX-repeat hexadecapeptide Biochemistry. 32: 10580-10590. PMID 8399202 DOI: 10.1021/Bi00091A007  0.301
1993 Daragan VA, Mayo KH. Tri- and diglycine backbone rotational dynamics investigated by 13C NMR multiplet relaxation and molecular dynamics simulations. Biochemistry. 32: 11488-99. PMID 8218215 DOI: 10.1021/Bi00094A004  0.302
1992 Daragan VA, Mayo KH. 13C-{1H} NMR/NOE and multiplet relaxation data in modeling protein dynamics of a collagen13C-enriched glycine GXX repeat motif hexadecapeptide 2,1 Journal of the American Chemical Society. 114: 4326-4331. DOI: 10.1021/Ja00037A043  0.308
1991 Burke C, Mayo KH, Skubitz APN, Furcht LT. 1H NMR and CD secondary structure analysis of cell adhesion promoting peptide F-9 from laminin Journal of Biological Chemistry. 266: 19407-19412. PMID 1918053  0.327
1991 Mayo KH, Parra-Diaz D, McCarthy JB, Chelberg M. Cell adhesion promoting peptide GVKGDKGNPGWPGAP from the collagen type IV triple helix: Cis/trans proline-induced multiple 1H NMR conformations and evidence for a KG/PG multiple turn repeat motif in the all-trans proline state Biochemistry. 30: 8251-8267. PMID 1868097  0.323
1985 Mayo KH, Prestegard JH. Acyl carrier protein from Escherichia coli. Structural characterization of short-chain acylated acyl carrier proteins by NMR Biochemistry. 24: 7834-7838. PMID 3912008 DOI: 10.1021/Bi00347A049  0.47
1983 Mayo KH, Kucheida D, Parak F, Chien JC. Structural dynamics of human deoxyhemoglobin and hemochrome investigated by nuclear gamma resonance absorption (Mössbauer) spectroscopy. Proceedings of the National Academy of Sciences of the United States of America. 80: 5294-6. PMID 6577425 DOI: 10.1073/Pnas.80.17.5294  0.558
1983 Mayo KH, Tyrell PM, Prestegard JH. Acyl carrier protein from Escherichia coli I. Aspects of the solution structure as evidenced by proton nuclear overhauser experiments at 500 MHz Biochemistry. 22: 4485-4493. PMID 6354258 DOI: 10.1021/Bi00288A021  0.463
1981 Mayo KH, Parak F, Mössbauer RL. Observations of elastic and quasi-elastic nuclear gamma resonance absorption in hemoglobin crystals Physics Letters A. 82: 468-470. DOI: 10.1016/0375-9601(81)90283-8  0.53
1980 Mayo KH, Chien JC. Effect of temperature on functional properties of carp hemoglobin. Journal of Molecular Biology. 142: 63-73. PMID 7431410 DOI: 10.1016/0022-2836(80)90206-5  0.491
1980 Chien JC, Mayo KH. Carp hemoglobin. II. The alkaline Bohr effect. The Journal of Biological Chemistry. 255: 9800-6. PMID 7430104  0.493
1980 Chien JC, Mayo KH. Carp hemoglobin. I. Precise oxygen equilibrium and analysis according to the models of Adair and of Monod, Wyman, and Changeux. The Journal of Biological Chemistry. 255: 9790-9. PMID 7430103  0.502
1980 Chien JC, Dickinson LC, Snyder FW, Mayo KH. Circular dichroism and spin-label studies of carp hemoglobin. Journal of Molecular Biology. 142: 75-91. PMID 6253650 DOI: 10.1016/0022-2836(80)90207-7  0.532
1979 Mayo KH, Chien JC. Carp hemoglobin. V. Effects of pH and P6-inositol on autooxidation. Biochimica Et Biophysica Acta. 581: 44-50. PMID 41592 DOI: 10.1016/0005-2795(79)90219-8  0.493
Show low-probability matches.